Frohlich Mark W
Rigel Pharmaceuticals, Inc. · Director
Frohlich Mark W is listed in public filings as director. This Frohlich Mark W insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL). Investors use Frohlich Mark W's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --7k shares | Grant / ExerciseMay 15, 2026 | Disclosure amount unavailable5.8k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --1.3k shares | Grant / ExerciseMay 23, 2025 | Disclosure amount unavailable1.3k shares | -- | -- | |
| $28k1.5k shares | Grant / ExerciseMay 23, 2025 | $28.4K1.5k shares | $18.95 | -- | |
| $236k12k shares | Grant / ExerciseMar 6, 2025 | $236.4K12k shares | $19.70 | -- |